PENALTIES.

SEC. 103. PENALTIES.(a) Prohibited Acts.—Section 301 (21 U.S.C. 331) is amended by adding at the end the following:“(ccc)(1) The resale of a compounded drug that is labeled ‘not for resale’ in accordance with section 503B.“(2) With respect to a drug to be compounded pursuant to section 503A or 503B, the intentional falsification of a prescription, as applicable.“(3) The failure to report drugs or adverse events by an entity that is registered in accordance with subsection (b) of section 503B.”.(b) Misbranded Drugs.—Section 502 (21 U.S.C. 352) is amended by adding at the end the following:“(bb) If the advertising or promotion of a compounded drug is false or misleading in any particular.”.